Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bizzarro

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 19, 2004
The role of brain infarcts and hippocampal atrophy in subcortical ischaemic vascular dementiaG Gainotti, A Acciarri, A Bizzarro, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1995
Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmosL Mansi, P F Rambaldi, A Bizzarro, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1989
Serum neopterin levels in liver cirrhosisS Antoniello, M Russo, A Bizzarro, et al.
Neuroscience Letters|February 16, 2010
The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patientsA Valenza, A Bizzarro, C Marra, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenomaA De Bellis, A Bizzarro, A Gattoni, et al.
Clinical Endocrinology|February 1, 1994
Detection of vasopressin cell antibodies in some patients with autoimmune endocrine diseases without overt diabetes insipidusA De Bellis, A Bizzarro, V Amoresano Paglionico, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's diseaseS Laureti, A De Bellis, V I Muccitelli, et al.
Minerva Endocrinologica|March 1, 1996
[Autoimmune Addison's disease. Current knowledge and prospects]A De Bellis, A Bizzarro, F Fiordelisi, et al.
Pituitary|October 15, 2013
Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarismA De Bellis, A Dello Iacovo, G Bellastella, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case reportA De Bellis A, A Falorni, S Laureti, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 19, 2004
The role of brain infarcts and hippocampal atrophy in subcortical ischaemic vascular dementiaG Gainotti, A Acciarri, A Bizzarro, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|June 1, 1995
Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmosL Mansi, P F Rambaldi, A Bizzarro, et al.
Journal of Biological Regulators and Homeostatic Agents|October 1, 1989
Serum neopterin levels in liver cirrhosisS Antoniello, M Russo, A Bizzarro, et al.
Neuroscience Letters|February 16, 2010
The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patientsA Valenza, A Bizzarro, C Marra, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenomaA De Bellis, A Bizzarro, A Gattoni, et al.
Clinical Endocrinology|February 1, 1994
Detection of vasopressin cell antibodies in some patients with autoimmune endocrine diseases without overt diabetes insipidusA De Bellis, A Bizzarro, V Amoresano Paglionico, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's diseaseS Laureti, A De Bellis, V I Muccitelli, et al.
Minerva Endocrinologica|March 1, 1996
[Autoimmune Addison's disease. Current knowledge and prospects]A De Bellis, A Bizzarro, F Fiordelisi, et al.
Pituitary|October 15, 2013
Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarismA De Bellis, A Dello Iacovo, G Bellastella, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2001
Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case reportA De Bellis A, A Falorni, S Laureti, et al.
Pageof 7